Information  X 
Enter a valid email address

Grupo Clarin S.A. (GCLA)

  Print      Mail a friend

Wednesday 20 June, 2018

Grupo Clarin S.A.

Grupo Clar�n Settles Claims

RNS Number : 9608R
Grupo Clarin S.A.
20 June 2018
 

 

 

GRUPO CLARIN S.A.

Grupo Clarín Settles Claims

 

On 19 June 2018, Grupo Clarín S.A. (the "Company") informed the Argentine Securities Commission and the Buenos Aires Stock Exchange that on 15 June 2018 the Company had reached a settlement with América TV S.A., SupercableCanal S.A., Supercanal S.A, José Luis Manzano, Daniel Eduardo Vila-and their respective related companies (jointly, the "Supercanal Group") and Telecom Argentina S.A. ("Telecom"), whereby, in order to terminate the various reciprocal claims filed among the parties-and their shareholders and/or controlled and/or related companies-described in the settlement agreement, in connection with the ownership of an equity participation in Supercanal Holding S.A. (currently Supercanal S.A.)-and related disputes-(the "Judicial Claims"). Pursuant the settlement, any claims that the parties may have against each other-and/or their respective controlled and related companies, and/or their respective directors and/or shareholders-in connection with the Judicial Claims shall be deemed terminated; all costs of the Judicial Claims shall be borne by the Supercanal Group, except for each party's attorneys' fees.

 

 

Enquiries:

 

In Buenos Aires:

Agustín Medina Manson/Patricio Gentile

Grupo Clarín

Tel: +5411 4309 7215

Email: [email protected] 

 

In London:

Alex Money

Jasford IR

Tel: +44 20 3289 5300

Email: [email protected] 

 

In New York:

Melanie Carpenter

I-advize Corporate Communications

Tel: +1 212 406 3692

Email: [email protected]

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
STRLIFVERIIIFIT

a d v e r t i s e m e n t